New England Biolabs Executive and Leadership Team

Salvatore Russello, the Chief Executive Officer at New England Biolabs, directs the company's overall strategic vision and operational execution. Russello guides the organization's commitment to producing and supplying recombinant and native enzyme reagents essential for life science research. This leadership encompasses fostering innovation in areas such as genome editing, synthetic biology, and next-generation sequencing. Salvatore Russello ensures the company's continued provision of free access to critical research tools like REBASE, InBASE, and Polbase, underscoring NEB's dedication to advancing scientific discovery globally. The Chief Executive Officer's role involves aligning departmental objectives with the company's long-standing mission to support researchers worldwide, driving growth and maintaining NEB's position as a leader in the biotechnology sector.

Richard Ireland, the Chief Financial Officer at New England Biolabs, manages all fiscal operations and financial strategy. Ireland oversees the company's financial health, ensuring robust resource allocation for research, development, and production of enzyme reagents. This involves meticulous budgeting, forecasting, and financial reporting to support NEB's mission in life science research, genome editing, and next-generation sequencing. Richard Ireland's financial oversight extends to managing investments in new technologies and maintaining the company's private ownership structure. The Chief Financial Officer plays a crucial part in sustaining the free access provided to research tools like REBASE and InBASE, balancing operational costs with the company's commitment to scientific accessibility. Ireland's expertise ensures financial stability and supports strategic expansion initiatives.

Hiroshi Toshishige, the Neb Inc President & General Manager (Japan) at New England Biolabs, spearheads the company's strategic initiatives and operational management within the Japanese market. Toshishige drives the expansion and delivery of NEB's recombinant and native enzyme reagents, supporting life science research, genome editing, and next-generation sequencing across Japan. This leadership role involves adapting global strategies to local market needs, ensuring robust supply chain operations, and fostering strong relationships with Japanese researchers and institutions. Hiroshi Toshishige oversees the localized implementation of NEB's commitment to providing essential research tools, including REBASE and InBASE, to the scientific community in Japan. The Neb Inc President & General Manager (Japan) ensures compliance with regional regulations and contributes significantly to NEB's international growth objectives, reinforcing the company's global impact.

Lennox Brown, the Chief Information Officer & Director, Information Technology at New England Biolabs, architects and directs the company's technological infrastructure and digital strategy. Brown is responsible for implementing and managing IT systems that support the production and supply of enzyme reagents for life science research, genome editing, and next-generation sequencing. This includes ensuring the integrity and accessibility of NEB's research tools such as REBASE and Polbase. Lennox Brown oversees cybersecurity measures, data management, and the integration of advanced technologies to enhance operational efficiency and support scientific innovation. The Chief Information Officer & Director, Information Technology ensures seamless digital operations, facilitating collaboration among research teams and supporting the company's global market presence. Brown's leadership drives technological advancements critical to NEB's mission.